{"organizations": [], "uuid": "66f8b775b729ec386f416fcfcf97ec8a463bf5a2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://feeds.bio-medicine.org/latest-medical-technology", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Gastroparesis-Pipeline-Researched-for-H2-2015-in-New-Report-49251-1/", "country": "US", "title": "Gastroparesis Pipeline Researched for H2 2015 in New Report", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Gastroparesis Pipeline Researched for H2 2015 in New Report", "spam_score": 0.0, "site_type": "news", "published": "2015-10-22T20:48:00.000+03:00", "replies_count": 0, "uuid": "66f8b775b729ec386f416fcfcf97ec8a463bf5a2"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Gastroparesis-Pipeline-Researched-for-H2-2015-in-New-Report-49251-1/", "ord_in_thread": 0, "title": "Gastroparesis Pipeline Researched for H2 2015 in New Report", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Date:10/22/2015 \nPUNE, India , October 23, 2015 /PRNewswire/ -- \nRnRMarketResearch.com adds \"Gastroparesis - Pipeline Review, H2 2015\" market research report to its store, which provides an overview of the Gastroparesis's therapeutic pipeline and covers current updates on the sector. \nThis report provides comprehensive information on the therapeutic development for Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastroparesis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. \nCompanies discussed in this report include GlaxoSmithKline Plc and RaQualia Pharma Inc. Complete report on H2 2015 pipeline review of Gastroparesis with 16 market data tables and 11 figures, spread across 40 pages is available at http://www.rnrmarketresearch.com/gastroparesis-pipeline-review-h2-2015-market-report.html . \nDrugs Profiles discussed in this report include camicinal, ETX-101, ETX-301, NG-101, RQ- 10, RQ-00201894 and velusetrag hydrochloride. Featured News & Press Releases mentioned in this report are May 18, 2015: Theravance Biopharma Presents Positive Phase 2 Study Data on Velusetrag (TD-5108) for Treatment of Gastroparesis in \"Poster of Distinction\" at Digestive Disease Week (DDW) 2015. Mar 12, 2015: Theravance Biopharma Announces Initiation of Phase 2b Study of Velusetrag (TD-5108) for the Treatment of Gastroparesis. Jan 07, 2014: RaQualia Receives a Patent Allowance for Motilin Receptor Agonist in the USA . Jan 08, 2013: Theravance And Alfa Wassermann Announce Initiation Of Phase II Study With Velusetrag For Gastroparesis. Sep 14, 2012: RaQualia Pharma's Motilin Receptor Agonist RQ-00201894 Advances To Pre-clinical Stage. \nScope of this report: The report provides a snapshot of the global therapeutic landscape of Gastroparesis and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Gastroparesis and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Gastroparesis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects. Coverage of the Gastroparesis pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products. \nOrder a copy of Gastroparesis - Pipeline Review, H2 2015 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=422200 . \nOther reports on gastrointestinal therapeutics available with RnRMarketResearch.com include: \nDigestive Remedies Industry Forecasts - China Focus: This research focuses on industry trends and forecasts with historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. The sector's economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products. Read more at http://www.rnrmarketresearch.com/digestive-remedies-industry-forecasts-china-focus-market-report.html . \nGastric Ulcers - Pipeline Review, H2 2015: Spread across 43 pages, this report talks about companies like Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Priaxon AG and Sihuan Pharmaceutical Holdings Group Ltd. Read more at http://www.rnrmarketresearch.com/gastric-ulcers-pipeline-review-h2-2015-market-report.html . \nAbout Us: \nRnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. \nContact: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar", "external_links": [], "published": "2015-10-22T20:48:00.000+03:00", "crawled": "2015-10-23T11:28:27.914+03:00", "highlightTitle": ""}